0000950137-01-504157.txt : 20011101
0000950137-01-504157.hdr.sgml : 20011101
ACCESSION NUMBER: 0000950137-01-504157
CONFORMED SUBMISSION TYPE: 8-K
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20011030
ITEM INFORMATION: Financial statements and exhibits
ITEM INFORMATION:
FILED AS OF DATE: 20011030
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PERRIGO CO
CENTRAL INDEX KEY: 0000820096
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 382799573
STATE OF INCORPORATION: MI
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 8-K
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19725
FILM NUMBER: 1770128
BUSINESS ADDRESS:
STREET 1: 515 EASTERN AVENUE
CITY: ALLEGAN
STATE: MI
ZIP: 49010
BUSINESS PHONE: 6166738451
MAIL ADDRESS:
STREET 1: 515 EASTERN AVENUE
CITY: ALLEGAN
STATE: MI
ZIP: 49010
8-K
1
c65686e8-k.txt
FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
October 30, 2001
PERRIGO COMPANY
--------------------------------------------------
(Exact name of registrant as specified in charter)
MICHIGAN 0-19725 38-2799573
--------------- ------------ -----------------
(State of other (Commission (I.R.S. Employer
Jurisdiction of File Number) Identification
Incorporation) Number)
515 Eastern Avenue, Allegan, Michigan 49010
------------------------------------------ -----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
(616) 673-8451
--------------
Item 7(c). Exhibits
Exhibit 99 Annual Shareholders' Meeting Slides
ITEM 9. Regulation FD Disclosure
On October 30, 2001, The Perrigo Company held its Annual Shareholders' Meeting
at the Griswold Auditorium, Allegan, Michigan.
The Annual Shareholders' Meeting slides presented are Exhibit 99.
Certain statements in these slides are forward-looking statements within the
meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and
are subject to the safe harbor created thereby. Please see the "Cautionary Note
Regarding Forward-Looking Statements" on pages 24 - 29 of the Company's Form
10-K for the year ended June 30, 2001 for a discussion of certain important
factors that relate to forward-looking statements contained in these slides. In
addition, the Company's future results may be affected by the impact of events
flowing from the September 11, 2001 terrorist attacks. Although the Company
believes that the expectations reflected in these forward-looking statements are
reasonable, it can give no assurance that such expectations will prove to be
correct. Unless otherwise required by applicable securities laws, the Company
disclaims any intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise.
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PERRIGO COMPANY
(Registrant)
By: /s/ Douglas R. Schrank
-----------------------------------
Dated: October 30, 2001 Douglas R. Schrank
Executive Vice President and
Chief Financial Officer
(Principal Accounting and
Financial Officer)
Exhibit Index
Exhibit 99 - Annual Shareholders' Meeting Slides
EX-99
3
c65686ex99.txt
ANNUAL SHAREHOLDERS' MEETING SLIDES
WELCOME TO THE 2001
ANNUAL MEETING OF SHAREHOLDERS
[PERRIGO LOGO]
ALLEGAN, MICHIGAN
OCTOBER 30, 2001
[PERRIGO LOGO]
STORE BRAND MARKET LEADER
[PHOTO OF MEDICINE]
[PERRIGO LOGO]
NET SALES
1999 692
2000 727
2001 766
[BAR GRAPH]
[PERRIGO LOGO]
OPERATING INCOME
1999 LESS RUSSIA CHARGES 29.8
2000 35.9
2001 LESS PPA CHARGES 40.1 61.1
[BAR GRAPH]
NET INCOME
1999 9.4
2000 19.3
2001 27.7 41.1
[BAR GRAPH]
[PERRIGO LOGO]
DILUTED EARNINGS PER SHARE
1999 $0.13
2000 $0.26
2001 $0.37 $0.55
[BAR GRAPH]
[PERRIGO LOGO]
STOCK PRICE FROM 6/30/00 TO 6/29/01
$6.31 TO $16.69
[A GRAPH]
[PERRIGO LOGO]
CYCLE OF RECOVERY
Financial ------ > Operations ------ > Growth
| | / |
| | / |
| | / |
| | / |
FY2000 FY2001/02 FY2002/03
[PERRIGO LOGO]
[WRAFTON LABORATORIES LOGO]
[PHOTO OF LABORATORIES]
[PERRIGO LOGO]
Rx(2) OTC SWITCH
Near-term Opportunities
- Advil(R) Cold/Sinus
- Children's Motrin(R)
Suspension New Flavors
[PHOTO OF MEDICINE]
- Excedrin(R) Migraine
- Monistat(R) 1
- Pepcid(R) AC Chewable
[PERRIGO LOGO]
[PHOTO OF MEDICINE]
[PERRIGO LOGO]
[PHOTO OF MEDICINE]
[PERRIGO LOGO]
FIRST QUARTER NET SALES
[BAR GRAPH]
2000 192
2001 192
2002 217
[PERRIGO LOGO]
FIRST QUARTER NET INCOME
[BAR GRAPH]
2000 9.6
2001 10.5
2002 13.1
[PERRIGO LOGO]
FIRST QUARTER EARNINGS PER SHARE
[BAR GRAPH]
2000 $0.13
2001 $0.14
2002 $0.17
[PERRIGO LOGO]
[PERRIGO(R) LOGO]
- Clear market leader
[PERRIGO(R) LOGO]
[PERRIGO(R) LOGO]
- Clear market leader
- Retailer relationships
[PERRIGO(R) LOGO]
[PERRIGO(R) LOGO]
- Clear market leader
- Retailer relationships
- Solid financials
[PERRIGO(R) LOGO]
[PERRIGO(R) LOGO]
- Clear market leader
- Retailer relationships
- Solid financials
- Productivity improvement
[PERRIGO(R) LOGO]
[PERRIGO(R) LOGO]
- Clear market leader
- Retailer relationships
- Solid financials
- Productivity improvement
- Understand the Store Brand market better
than anyone
[PERRIGO(R) LOGO]
[PERRIGO(R) LOGO]